These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6154895)

  • 1. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol acutely reduces LH and prolactin secretion: possible involvement by dopamine.
    Ching M; Lin YC
    Alcohol; 1994; 11(2):105-12. PubMed ID: 8204196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
    Faure N; Cronin MJ; Martial JA; Weiner RI
    Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
    Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF
    Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors.
    Hjorth S; Eriksson E; Andersson B
    Eur J Pharmacol; 1986 Jun; 125(3):421-8. PubMed ID: 3755402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP; Stringer LC; Freeman ME
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT; Moore KE; Riegle GD
    Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological manipulation of anterior pituitary dopamine content in the male rat: relationship to serum prolactin concentration and lysosomal enzyme activity.
    Demarest KT; Riegle GD; Moore KE
    Endocrinology; 1984 Aug; 115(2):493-500. PubMed ID: 6745164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
    Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B
    Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
    Lafond J; Ducharme JR; Collu R
    Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland.
    Oomizu S; Boyadjieva N; Sarkar DK
    Alcohol Clin Exp Res; 2003 Jun; 27(6):975-80. PubMed ID: 12824819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dopamine on the altered release of prolactin, luteinizing hormone, and follicle-stimulating hormone induced by interleukin-2 in vitro.
    Karanth S; Marubayashi U; McCann SM
    Neuroendocrinology; 1992 Dec; 56(6):871-80. PubMed ID: 1369597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of ions and hypothalamic factors on the in vitro activity of rainbow trout prolactin cells.
    Johnston LR; Wigham T
    Gen Comp Endocrinol; 1990 Aug; 79(2):253-60. PubMed ID: 1697274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I; Garris PA; Ben-Jonathan N
    Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.